Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 21, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 March 2024 - 14:23

Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 21, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/ameluz

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters